n | % | |
---|---|---|
Immunosuppressive regimen | ||
Methylprednisolone pulse | 20/29 | 69 |
Prednisone, 0.5 to 1 mg/kg/d | 28/29 | 96 |
CYC | 16/29 | 55 |
IVIG | 8/29 | 28 |
Plasma exchanges | 4/29 | 14 |
MMF (first-line) | 2/29 | 7 |
MMF (maintenance) | 10/29 | 34 |
Outcome | ||
Median length of stay at hospital, days (range) | 42.8 (8–227) | |
Median followup, mos (range) | 37 (4–115) | |
Conventional unit only | 4 | |
ICU | 25 | |
Death due to LM | 2 | |
Total deaths | 3 | |
Relapse | 1 | |
Treatment at last visit* | ||
Beta blockers | 5/25 | 20 |
ACE inhibitors | 8/25 | 32 |
HCQ | 22/25 | 88 |
Prednisone ≤ 10 mg/d | 17/25 | 68 |
Prednisone > 10 mg/d | 2/25 | 8 |
MMF | 7/25 | 28 |
AZA | 1/25 | 4 |
MTX | 1/25 | 4 |
↵* N = 25 (3 dead, 1 lost to followup). CYC: cyclophosphamide; IVIG: intravenous immunoglobulins; ICU: intensive care unit; LM: lupus myocarditis; ACE inhibitors: angiotensin-converting enzyme inhibitors; HCQ: hydroxychloroquine; MMF: mycophenolate mofetil; AZA: azathioprine; MTX: methotrexate.